Multidisciplinary team meetings in Hematology: a national mixed-methods study.

Cancer care team Cancer policy Care organization Decision-making Hematology Multidisciplinary team meetings

Journal

BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800

Informations de publication

Date de publication:
07 Oct 2023
Historique:
received: 03 12 2022
accepted: 21 09 2023
medline: 1 11 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: epublish

Résumé

Multidisciplinary team meetings are a current international practice in cancer care, but to date, few data exist on the specificity of its practice in hematology.In this manuscript, we present the result of the first national study, realized with quantitative and qualitative methods in France, which brings new insights in order to improve the collegial decision-making process.To improve the effectiveness of MDTMs, the needs to focus on complex cases, to enhance patient centeredness and teamwork are relevant aspects, and a specific focus on hematological particularities is warranted to truly improve process.Background Understanding the Multidisciplinary team meetings (MDTMs) process in different medical specialties facilitates the identification of core factors supporting effective MDTM work. Our mixed-methods study explores the participants' perceptions of hematology MDTMs.Design Online questionnaires collected data concerning the decision-making process, benefits and inconveniences of MDTMs for both patients and professionals. Semi-directive phone interviews were conducted and analyzed, thereby supplying qualitative data.Results A total of 205 professionals responded to the questionnaire and 22 participated in the qualitative interviews. The data indicate the unique characteristics of hematology, including a specific definition of collegiality, the frequent solicitation of expert advice and the anticipation of treatment even prior to the occurrence of MDTMs. Additional information concerning patients' wishes and psychosocial conditions are also needed. Participants emphasize the subjective aspects and the impact of the climate of MDTMs on medical decisions.Conclusion Although MDTMs are recognized to be a valuable tool, organizational and relational issues may interfere with their efficiency.To improve the effectiveness of MDTMs, the needs to focus on complex cases, to enhance patient centeredness and teamwork are relevant aspects. A specific focus on hematological particularities might be warranted to truly improve the collegial decision-making process in the context of hematology.

Identifiants

pubmed: 37805458
doi: 10.1186/s12885-023-11431-y
pii: 10.1186/s12885-023-11431-y
pmc: PMC10560417
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

950

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Engelhardt M, Ihorst G, Schumacher M, Rassner M, Gengenbach L, Moller M, Shoumariyeh K, Neubauer J, Farthmann J, Herget G, Wasch R. Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures. BMC Cancer. 2021;21(1):173. https://doi.org/10.1186/s12885-021-07878-6 . Epub 2021/02/19. PubMed PMID: 33596881; PMCID: PMC7891134.
doi: 10.1186/s12885-021-07878-6 pubmed: 33596881 pmcid: 7891134
Jalil R, Ahmed M, Green JS, Sevdalis N. Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: an interview study of the provider perspective. Int J Surg. 2013;11(5):389–94. https://doi.org/10.1016/j.ijsu.2013.02.026 . Epub 2013/03/19. PubMed PMID: 23500030.
doi: 10.1016/j.ijsu.2013.02.026 pubmed: 23500030
Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol. 2011;18(8):2116–25. https://doi.org/10.1245/s10434-011-1675-6 . Epub 2011/03/29. PubMed PMID: 21442345.
doi: 10.1245/s10434-011-1675-6 pubmed: 21442345
Selby P, Popescu R, Lawler M, Butcher H, Costa A. The value and future developments of multidisciplinary team cancer care. Am Soc Clin Oncol Educ Book. 2019;39:332–40. https://doi.org/10.1200/EDBK_236857 . Epub 2019/05/18. PubMed PMID: 31099640.
doi: 10.1200/EDBK_236857 pubmed: 31099640
Walraven JEW, van der Hel OL, van der Hoeven JJM, Lemmens V, Verhoeven RHA, Desar IME. Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review. BMC Health Serv Res. 2022;22(1):829. https://doi.org/10.1186/s12913-022-08112-0 . Epub 2022/06/28. PubMed PMID: 35761282; PMCID: PMC9238082.
doi: 10.1186/s12913-022-08112-0 pubmed: 35761282 pmcid: 9238082
Cannell E. The French Cancer Plan: an update. Lancet Oncol. 2005;6(10):738. https://doi.org/10.1016/s1470-2045(05)70369-7 . Epub 2005/10/19. PubMed PMID: 16229093.
doi: 10.1016/s1470-2045(05)70369-7 pubmed: 16229093
Bas Theron F, Gresy B, Guillermo V, Chambaud L. Évaluation des mesures du plan cancer 2003–2007 relatives au dépistage et à l’organisation des soins. Inspection générale des affaires sociales; 2009.
Descotes JL, Guillem P, Bondil P, Colombel M, Chabloz C. Assessment of cancer RCP meetings in Rhone-Alpes: a survey on the ground. Prog Urol. 2010;20(9):651–6. https://doi.org/10.1016/j.purol.2010.03.012 . Epub 2010/10/19. PubMed PMID: 20951934.
doi: 10.1016/j.purol.2010.03.012 pubmed: 20951934
Guillem P, Bolla M, Courby S, Descotes JL, Laramas M, Moro-Sibilot D. Multidisciplinary team meetings in cancerology: setting priorities for improvement. Bull Cancer. 2011;98(9):989–98. https://doi.org/10.1684/bdc.2011.1428 . Epub 2011/09/13. PubMed PMID: 21908262.
doi: 10.1684/bdc.2011.1428 pubmed: 21908262
Orgerie MB, Duchange N, Pelicier N, Chapet S, Dorval E, Rosset P, Lemarie E, Herve C, Moutel G. Decision process in oncology: the importance of multidisciplinary meeting. Bull Cancer. 2010;97(2):255–64. https://doi.org/10.1684/bdc.2009.0957 . Epub 2009/10/15. PubMed PMID: 19825531.
doi: 10.1684/bdc.2009.0957 pubmed: 19825531
Soukup T, Petrides KV, Lamb BW, Sarkar S, Arora S, Shah S, Darzi A, Green JSA, Sevdalis N. The anatomy of clinical decision-making in multidisciplinary cancer meetings: a cross-sectional observational study of teams in a natural context. Medicine (Baltimore). 2016;95(24):e3885.
doi: 10.1097/MD.0000000000003885 pubmed: 27310981
Hong NJ, Wright FC, Gagliardi AR, Paszat LF. Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review. J Surg Oncol. 2010;102(2):125–34. https://doi.org/10.1002/jso.21589 . Epub 2010/07/22. PubMed PMID: 20648582.
doi: 10.1002/jso.21589 pubmed: 20648582
Lamb BW, Wong HW, Vincent C, Green JS, Sevdalis N. Teamwork and team performance in multidisciplinary cancer teams: development and evaluation of an observational assessment tool. BMJ Qual Saf. 2011;20(10):849–56. https://doi.org/10.1136/bmjqs.2010.048660 . Epub 2011/05/26. PubMed PMID: 21610266.
doi: 10.1136/bmjqs.2010.048660 pubmed: 21610266
Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JS. Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature. J Multidiscip Healthc. 2018;11:49–61. https://doi.org/10.2147/JMDH.S117945 . Epub 2018/02/07. PubMed PMID: 29403284; PMCID: PMC5783021.
doi: 10.2147/JMDH.S117945 pubmed: 29403284 pmcid: 5783021
Lamprell K, Arnolda G, Delaney GP, Liauw W, Braithwaite J. The challenge of putting principles into practice: Resource tensions and real-world constraints in multidisciplinary oncology team meetings. Asia Pac J Clin Oncol. 2019;15(4):199–207. https://doi.org/10.1111/ajco.13166 . Epub 2019/05/23. PubMed PMID: 31115170.
doi: 10.1111/ajco.13166 pubmed: 31115170
Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol. 2012;19(4):e232-8. https://doi.org/10.3747/co.19.944 . Epub 2012/08/10. PubMed PMID: 22876151; PMCID: PMC3410834.
doi: 10.3747/co.19.944 pubmed: 22876151 pmcid: 3410834
Lamb BW, Taylor C, Lamb JN, Strickland SL, Vincent C, Green JS, Sevdalis N. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol. 2013;20(5):1408–16. https://doi.org/10.1245/s10434-012-2676-9 . Epub 2012/10/23. PubMed PMID: 23086306.
doi: 10.1245/s10434-012-2676-9 pubmed: 23086306
Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, Crowe J, Costello AJ. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2016;42:56–72. https://doi.org/10.1016/j.ctrv.2015.11.007 . Epub 2015/12/09. PubMed PMID: 26643552.
doi: 10.1016/j.ctrv.2015.11.007 pubmed: 26643552
Berardi R, Morgese F, Rinaldi S, Torniai M, Mentrasti G, Scortichini L, Giampieri R. Benefits and limitations of a multidisciplinary approach in cancer patient management. Cancer Manag Res. 2020;12:9363–74. https://doi.org/10.2147/CMAR.S220976 . Epub 2020/10/17. PubMed PMID: 33061625; PMCID: PMC7533227.
doi: 10.2147/CMAR.S220976 pubmed: 33061625 pmcid: 7533227
Look Hong NJ, Gagliardi AR, Bronskill SE, Paszat LF, Wright FC. Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation. J Oncol Pract. 2010;6(2):61–8. https://doi.org/10.1200/JOP.091085 . Epub 2010/07/02. PubMed PMID: 20592777; PMCID: PMC2835483.
doi: 10.1200/JOP.091085 pubmed: 20592777 pmcid: 2835483
Habermann TM, Khurana A, Lentz R, Schmitz JJ, von Bormann AG, Young JR, Hunt CH, Christofferson SN, Nowakowski GS, McCullough KB, Horna P, Wood AJ, Macon WR, Kurtin PJ, Lester SC, Stafford SL, Chamarthy U, Khan F, Ansell SM, King RL. Analysis and impact of a multidisciplinary lymphoma virtual tumor board. Leuk Lymphoma. 2020;61(14):3351–9. https://doi.org/10.1080/10428194.2020.1817432 . Epub 2020/09/25. PubMed PMID: 32967496; PMCID: PMC8682150.
doi: 10.1080/10428194.2020.1817432 pubmed: 32967496 pmcid: 8682150
Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: a prospective correlational study. Ann Surg Oncol. 2013;20(3):715–22. https://doi.org/10.1245/s10434-012-2691-x . Epub 2012/10/16. PubMed PMID: 23064794.
doi: 10.1245/s10434-012-2691-x pubmed: 23064794
Le Divenah A, David S, Bertrand D, Chatel T, Viallards ML. Multidisciplinary consultation meetings: decision-making in palliative chemotherapy. Sante Publique. 2013;25(2):129–35 Epub 2013/08/24 PubMed PMID: 23964537.
pubmed: 23964537
Atwell D, Vignarajah DD, Chan BA, Buddle N, Manders PM, West K, Knesl M, Long J, Min M. Referral rates to multidisciplinary team meetings: is there disparity between tumour streams? J Med Imaging Radiat Oncol. 2019;63(3):378–82. https://doi.org/10.1111/1754-9485.12851 . Epub 2019/01/10. PubMed PMID: 30623607.
doi: 10.1111/1754-9485.12851 pubmed: 30623607
Lamb BW, Sevdalis N, Taylor C, Vincent C, Green JS. Multidisciplinary team working across different tumour types: analysis of a national survey. Ann Oncol. 2012;23(5):1293–300. https://doi.org/10.1093/annonc/mdr453 . Epub 2011/10/22. PubMed PMID: 22015450.
doi: 10.1093/annonc/mdr453 pubmed: 22015450
Ponto J. Understanding and evaluating survey research. J Adv Pract Oncol. 2015;6(2):168–71 Epub 2015 Mar 1. PMID: 26649250; PMCID: PMC4601897.
pubmed: 26649250 pmcid: 4601897
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. https://doi.org/10.1093/intqhc/mzm042 . (Epub 2007 Sep 14 PMID: 17872937).
doi: 10.1093/intqhc/mzm042 pubmed: 17872937
Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative Research Practice: A Guide for Social Science Students and Researchers. Second Edition ed: SAGE Publications Ltd; 2013.
Winters DA, Soukup T, Sevdalis N, Green JSA, Lamb BW. The cancer multidisciplinary team meeting: in need of change? history, challenges and future perspectives. BJU Int. 2021;128(3):271–9. https://doi.org/10.1111/bju.15495 . Epub 2021/05/25. PubMed PMID: 34028162.
doi: 10.1111/bju.15495 pubmed: 34028162
Geerts PAF, van der Weijden T, Savelberg W, Altan M, Chisari G, Launert DR, Mesters H, Pisters Y, van Heumen M, Hermanns R, Bos GMJ, Moser A. The next step toward patient-centeredness in multidisciplinary cancer team meetings: an interview study with professionals. J Multidiscip Healthc. 2021;14:1311–24.
doi: 10.2147/JMDH.S286044 pubmed: 34113119 pmcid: 8187002
Lamb BW, Green JS, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. 2013;217(3):412–20.
doi: 10.1016/j.jamcollsurg.2013.04.035 pubmed: 23891067
Restivo L, Apostolidis T, Bouhnik AD, Garciaz S, Aurran T, Julian-Reynier C. Patients’ non-medical characteristics contribute to collective medical decision-making at multidisciplinary oncological team meetings. PLoS One. 2016;11(5):e0154969.
doi: 10.1371/journal.pone.0154969 pubmed: 27167521 pmcid: 4864423
Rosell L, Wihl J, Nilbert M, Malmstrom M. Health professionals’ views on key enabling factors and barriers of national multidisciplinary team meetings in cancer care: a qualitative study. J Multidiscip Healthc. 2020;13:179–86. https://doi.org/10.2147/JMDH.S240140 . Epub 2020/02/28. PubMed PMID: 32103978; PMCID: PMC7029585.
doi: 10.2147/JMDH.S240140 pubmed: 32103978 pmcid: 7029585
Stairmand J, Signal L, Sarfati D, Jackson C, Batten L, Holdaway M, Cunningham C. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. Ann Oncol. 2015;26(7):1325–32. https://doi.org/10.1093/annonc/mdv025 . Epub 2015/01/22. PubMed PMID: 25605751.
doi: 10.1093/annonc/mdv025 pubmed: 25605751
Devitt B, Philip J, McLachlan SA. Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: health professionals’ perspectives. J Oncol Pract. 2010;6(6):e17-20. https://doi.org/10.1200/JOP.2010.000023 . Epub 2011/03/02. PubMed PMID: 21358945; PMCID: PMC2988673.
doi: 10.1200/JOP.2010.000023 pubmed: 21358945 pmcid: 2988673
Gray R, Gordon B, Meredith M. Patients’ Needs: Improving the Effectiveness of Multidisciplinary Team Meetings in Cancer Services2017.
Walsh J, Harrison JD, Young JM, Butow PN, Solomon MJ, Masya L. What are the current barriers to effective cancer care coordination? a qualitative study. BMC Health Serv Res. 2010;10:132.
doi: 10.1186/1472-6963-10-132 pubmed: 20482884 pmcid: 2891740
Hahlweg P, Didi S, Kriston L, Harter M, Nestoriuc Y, Scholl I. Process quality of decision-making in multidisciplinary cancer team meetings: a structured observational study. BMC Cancer. 2017;17(1):772.
doi: 10.1186/s12885-017-3768-5 pubmed: 29149872 pmcid: 5693525
Horlait M, De Regge M, Baes S, Eeckloo K, Leys M. Exploring non-physician care professionals’ roles in cancer multidisciplinary team meetings: A qualitative study. PLoS One. 2022;17(2):e0263611.
doi: 10.1371/journal.pone.0263611 pubmed: 35113976 pmcid: 8812975
Longino H. Science as social knowledge: Values and objectivity in scientific inquiry. Princeton University Press. 1990.
Yvonnet S. An analysis of medical decision making: the case of multidisciplinary team meetings. Bull Cancer. 2022;109(3):346–57.
doi: 10.1016/j.bulcan.2021.10.010 pubmed: 35078622
Sidhom MA, Poulsen M. Group decisions in oncology: doctors’ perceptions of the legal responsibilities arising from multidisciplinary meetings. J Med Imaging Radiat Oncol. 2008;52(3):287–92. https://doi.org/10.1111/j.1440-1673.2007.01916.x . Epub 2008/05/15. PubMed PMID: 18477124.
doi: 10.1111/j.1440-1673.2007.01916.x pubmed: 18477124
Orgerie MB, Duchange N, Pelicier N, Rosset P, Lemarie E, Dorval E, Chapet S, Herve C, Moutel G. Multidisciplinary meetings in oncology do not impact the physician-patient relationship. Presse Med. 2012;41(3 Pt 1):e87-94. https://doi.org/10.1016/j.lpm.2011.07.026 . Epub 2011/11/15. PubMed PMID: 22079306.
doi: 10.1016/j.lpm.2011.07.026 pubmed: 22079306
Taplin SH, Rodgers AB. Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care. J Natl Cancer Inst Monogr. 2010;2010(40):3–10.
doi: 10.1093/jncimonographs/lgq006 pubmed: 20386048 pmcid: 3482951
Taplin SH, Weaver S, Salas E, Chollette V, Edwards HM, Bruinooge SS, Kosty MP. Reviewing cancer care team effectiveness. J Oncol Pract. 2015;11(3):239–46. https://doi.org/10.1200/JOP.2014.003350 . Epub 2015/04/16. PubMed PMID: 25873056; PMCID: PMC4438110.
doi: 10.1200/JOP.2014.003350 pubmed: 25873056 pmcid: 4438110
Weaver SJ, Dy SM, Rosen MA. Team-training in healthcare: a narrative synthesis of the literature. BMJ Qual Saf. 2014;23(5):359–72. https://doi.org/10.1136/bmjqs-2013-001848 . Epub 2014/02/07. PubMed PMID: 24501181; PMCID: PMC3995248.
doi: 10.1136/bmjqs-2013-001848 pubmed: 24501181 pmcid: 3995248
Rosell L, Wihl J, Hagberg O, Ohlsson B, Nilbert M. Function, information, and contributions: an evaluation of national multidisciplinary team meetings for rare cancers. Rare Tumors. 2019;11:2036361319841696. https://doi.org/10.1177/2036361319841696 . Epub 2019/05/21. PubMed PMID: 31105919; PMCID: PMC6506921.
doi: 10.1177/2036361319841696 pubmed: 31105919 pmcid: 6506921
Wihl J, Rosell L, Bendahl PO, De Mattos CBR, Kinhult S, Lindell G, von Steyern FV, Nilbert M. Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care. Cancer Treat Res Commun. 2020;25:100231.
doi: 10.1016/j.ctarc.2020.100231 pubmed: 33157512
Walraven JEW, van der Meulen R, van der Hoeven JJM, Lemmens V, Verhoeven RHA, Hesselink G, Desar IME. Preparing tomorrow’s medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs. BMC Med Educ. 2022;22(1):502. https://doi.org/10.1186/s12909-022-03570-w . Epub 2022/06/28. PubMed PMID: 35761247; PMCID: PMC9238222.
doi: 10.1186/s12909-022-03570-w pubmed: 35761247 pmcid: 9238222

Auteurs

Alice Polomeni (A)

Clinical Hematology and Cellular Therapy Department, Hôpital Saint-Antoine - Assistance Publique- Hôpitaux de Paris, 184 Rue du Fbg Saint Antoine, 75012, Paris, France. alice.polomeni@aphp.fr.
Ethics Commission of the French Society of Hematology, Grenoble, France. alice.polomeni@aphp.fr.

Dominique Bordessoule (D)

Ethics Commission of the French Society of Hematology, Grenoble, France.
Hematology Department, Centre Hospitalo-Universitaire de Limoges, 2 Avenue Martin Luther King, 87000, Limoges, France.

Sandra Malak (S)

Ethics Commission of the French Society of Hematology, Grenoble, France.
Hematology Department of Institut Curie Hospital, Institut Curie-Saint-Cloud, 35 Rue Dailly, 92210, Saint-Cloud, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH